AMD - Age-Related Macular Degeneration
Ophthalmology·MeSH: Macular Degeneration
Prevalence
2000.0 / 100K
Incidence
200.0 / 100K/yr
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(2)
Phase 1(1)
Compare drugs
Frequently asked questions
How many drugs are in development for AMD - Age-Related Macular Degeneration?
BioSniper tracks 3 drugs in development for AMD - Age-Related Macular Degeneration across 1 company.
How many clinical trials target AMD - Age-Related Macular Degeneration?
There are 1 clinical trial targeting AMD - Age-Related Macular Degeneration tracked by BioSniper.
What is the prevalence of AMD - Age-Related Macular Degeneration?
The estimated prevalence of AMD - Age-Related Macular Degeneration is approximately 2000.0 per 100,000 population.
Deep-dive into AMD - Age-Related Macular Degeneration
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis